Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms

Trends in Microbiology

Volumn 22, Issue 6, 2014, Pages 326-333

  Van Acker, Heleen ^a   Van Dijck, Patrick ^b,c   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Antibiotics; Biofilm; Biofilm matrix; Efflux; Persisters; Resistance

Indexed keywords

AMINOGLYCOSIDE; BACTERIAL POLYSACCHARIDE; CIPROFLOXACIN; GENTAMICIN; GLUCAN SYNTHASE; GLUCOSYLTRANSFERASE; KANAMYCIN; MICONAZOLE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; ANTIINFECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ADAPTIVE BEHAVIOR; ANTIBIOTIC RESISTANCE; ANTIFUNGAL RESISTANCE; BACTERIAL GENE; BIOFILM; BURKHOLDERIA CENOCEPACIA; CANDIDA ALBICANS; EXTRACELLULAR MATRIX; FUNGAL GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HETEROZYGOSITY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PHYSICAL CHEMISTRY; PLANKTON; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; TRANSPOSON; BACTERIA; BACTERIAL PHENOMENA AND FUNCTIONS; BIOLOGICAL MODEL; DRUG EFFECTS; FUNGUS; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, FUNGAL; FUNGI; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84901588714     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2014.02.001     Document Type: Review

References (82)

1. Stoodley P., et al. Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 2002, 56:187-209.
2. Bjarnsholt T., et al. The in vivo biofilm. Trends Microbiol. 2013, 21:466-474.
3. Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358:135-138.
4. Hall-Stoodley L., et al. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004, 2:95-108.
5. Lewis K. Persister cells. Annu. Rev. Microbiol. 2010, 64:357-372.
6. Madsen J.S., et al. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol. Med. Microbiol. 2012, 65:183-195.
7. Savage V.J., et al. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob. Agents Chemother. 2013, 57:1968-1970.
8. Soto S.M. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence 2013, 4:223-229.
9. Mah T.F. Biofilm-specific antibiotic resistance. Future Microbiol. 2012, 7:1061-1072.
10. Coenye T. Response of sessile cells to stress: from changes in gene expression to phenotypic adaptation. FEMS Immunol. Med. Microbiol. 2010, 59:239-252.
11. Fux C.A., et al. Survival strategies of infectious biofilms. Trends Microbiol. 2005, 13:34-40.
12. Dwyer D.J., et al. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 2007, 3:91.
13. Dwyer D.J., et al. Role of reactive oxygen species in antibiotic action and resistance. Curr. Opin. Microbiol. 2009, 12:482-489.
14. Kohanski M.A., et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130:797-810.
15. Kohanski M.A., et al. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 2008, 135:679-690.
16. Keren I., et al. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 2013, 339:1213-1216.
17. Liu Y., Imlay J.A. Cell death from antibiotics without the involvement of reactive oxygen species. Science 2013, 339:1210-1213.
18. Fang F.C. Antibiotic and ROS linkage questioned. Nat. Biotechnol. 2013, 31:415-416.
19. Battán P.C., et al. Resistance to oxidative stress caused by ceftazidime and piperacillin in a biofilm of Pseudomonas. Luminescence 2004, 19:265-270.
20. Aiassa V., et al. Resistance to ciprofloxacin by enhancement of antioxidant defenses in biofilm and planktonic Proteus mirabilis. Biochem. Biophys. Res. Commun. 2010, 393:84-88.
21. Aiassa V., et al. Macromolecular oxidation in planktonic population and biofilms of Proteus mirabilis exposed to ciprofloxacin. Cell Biochem. Biophys. 2014, 68:49-54.
22. Jensen P.O., et al. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms. Pathog. Dis. 2014, 10.1111/2049-632X.12120.
23. Brochmann R.P., et al. Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation. Int. J. Antimicrob. Agents 2014, 43:140-147.
24. Nguyen D., et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011, 334:982-986.
25. Khakimova M., et al. The stringent response controls catalases in Pseudomonas aeruginosa and is required for hydrogen peroxide and antibiotic tolerance. J. Bacteriol. 2013, 195:2011-2020.
26. Van Acker H., et al. Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS ONE 2013, 8:e58943.
27. Sokol-Anderson M.L., et al. Amphotericin B-induced oxidative damage and killing of Candida albicans. J. Infect. Dis. 1986, 154:76-83.
28. Kobayashi D., et al. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob. Agents Chemother. 2002, 46:3113-3117.
29. François I.E., et al. Azoles: mode of antifungal action and resistance development. Effect of miconazole on endogenous reactive oxygen species production in Candida albicans. Curr. Med. Chem. 2006, 5:1-11.
30. Belenky P., et al. Fungicidal drugs induce a common oxidative-damage cellular death pathway. Cell Rep. 2013, 3:350-358.
31. Vandenbosch D., et al. Fungicidal activity of miconazole against Candida spp. biofilms. J. Antimicrob. Chemother. 2010, 65:694-700.
32. Bink A., et al. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob. Agents Chemother. 2011, 55:4033-4037.
33. De Brucker K., et al. Potentiation of antibiofilm activity of amphotericin B by superoxide dismutase inhibition. Oxid. Med. Cell. Longev. 2013, 2013:704654.
34. LaFleur M.D., et al. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 2006, 50:3839-3846.
35. Kumar A., Schweizer H.P. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv. Drug Deliv. Rev. 2005, 57:1486-1513.
36. Fernández L., Hancock R.E. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol. Rev. 2012, 25:661-681.
37. De Kievit T.R., et al. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 2001, 45:1761-1770.
38. Gillis R.J., et al. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 2005, 49:3858-3867.
39. Pamp S.J., et al. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol. 2008, 68:223-240.
40. Chiang W.C., et al. The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms. FEMS Immunol. Med. Microbiol. 2012, 65:245-256.
41. Zhang L., Mah T.F. Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J. Bacteriol. 2008, 190:4447-4452.
42. Mulet X., et al. Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth. Antimicrob. Agents Chemother. 2011, 55:4560-4568.
43. Ciofu O., et al. Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 2000, 45:9-13.
44. Bagge N., et al. Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 2004, 48:1168-1174.
45. Bagge N., et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob. Agents Chemother. 2004, 48:1175-1187.
46. Bazzini S., et al. Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS ONE 2011, 6:e18902.
47. Guglierame P., et al. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol. 2006, 6:66.
48. Buroni S., et al. Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol. 2009, 9:200.
49. Rushton L., et al. Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria. Antimicrob. Agents Chemother. 2013, 57:2972-2980.
50. Coenye T., et al. Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms. Antimicrob. Agents Chemother. 2011, 55:1912-1919.
51. Cannon R.D., et al. Efflux-mediated antifungal drug resistance. Clin. Microbiol. Rev. 2009, 22:291-321.
52. Sanglard D., Odds F.C. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2002, 2:73-85.
53. Taff H.T., et al. Mechanisms of Candida biofilm drug resistance. Future Microbiol. 2013, 8:1325-1337.
54. Mathé L., Van Dijck P. Recent insights into Candida albicans biofilm resistance mechanisms. Curr. Genet. 2013, 59:251-264.
55. Ramage G., et al. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 2002, 49:973-980.
56. Mukherjee P.K., et al. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect. Immun. 2003, 71:4333-4340.
57. Mateus C., et al. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob. Agents Chemother. 2004, 48:3358-3366.
58. Nailis H., et al. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms. Res. Microbiol. 2010, 161:284-292.
59. Nett J.E., et al. Time course global gene expression analysis of an in vivo Candida biofilm. J. Infect. Dis. 2009, 200:307-313.
60. Jefferson K.K., et al. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 2005, 49:2467-2473.
61. McNee S.G., et al. Effect of extracellular polysaccharides on diffusion of NaF and [14C]-sucrose in human dental plaque and in sediments of the bacterium Streptococcus sanguis 804 (NCTC 10904). Arch. Oral. Biol. 1982, 27:981-986.
62. Stewart P.S. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother. 1996, 40:2517-2522.
63. Stewart P.S. Diffusion in biofilms. J. Bacteriol. 2003, 185:1485-1491.
64. Gordon C.A., et al. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J. Antimicrob. Chemother. 1988, 22:667-674.
65. Nichols W.W., et al. The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J. Gen. Microbiol. 1989, 135:1291-1303.
66. Gordon C.A., et al. Use of slime dispersants to promote antibiotic penetration through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1991, 35:1258-1260.
67. Tseng B.S., et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ. Microbiol. 2013, 15:2865-2878.
68. Billings N., et al. The extracellular matrix component Psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilms. PLoS Pathog. 2013, 9:e1003526.
69. Colvin K.M., et al. The Pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog. 2011, 7:e1001264.
70. Mah T.F., et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003, 426:306-310.
71. Sadovskaya I., et al. High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: the ndvB gene is involved in the production of highly glycerol-phosphorylated beta-(1->3)-glucans, which bind aminoglycosides. Glycobiology 2010, 20:895-904.
72. Beaudoin T., et al. The biofilm-specific antibiotic resistance gene ndvB is important for expression of ethanol oxidation genes in Pseudomonas aeruginosa biofilms. J. Bacteriol. 2012, 194:3128-3136.
73. Baillie G.S., Douglas L.J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 2000, 46:397-403.
74. Al-Fattani M.A., Douglas L.J. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 2006, 55:999-1008.
75. Nett J., et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 2007, 51:510-520.
76. Nett J.E., et al. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J. Infect. Dis. 2010, 202:171-175.
77. Nett J.E., et al. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob. Agents Chemother. 2010, 54:3505-3508.
78. Vediyappan G., et al. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob. Agents Chemother. 2010, 54:2096-2111.
79. Taff H.T., et al. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog. 2012, 8:e1002848.
80. Mitchell K.F., et al. Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms. Antimicrob. Agents Chemother. 2013, 57:1918-1920.
81. Liao J., Sauer K. The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance. J. Bacteriol. 2012, 194:4823-4836.
82. Liao J., et al. The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms. J. Bacteriol. 2013, 195:3352-3363.